ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Abivax

Abivax (ABVX)

7.44
-0.31
(-4.00%)
마감 13 12월 1:30AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
7.44
매수가
7.32
매도가
7.66
거래량
18,973
7.36 일간 변동폭 7.76
7.36 52주 범위 15.42
market_cap
전일 종가
7.75
개장가
7.72
최근 거래 시간
10
@
7.44
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
22,682
발행 주식
62,928,818
배당수익률
-
주가수익률
-3.17
주당순이익(EPS)
-2.35
매출
4.62M
순이익
-147.74M

Abivax 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Paris, Paris, Fra
설립됨
-
Abivax is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker ABVX. The last closing price for Abivax was 7.75 €. Over the last year, Abivax shares have traded in a share price range of 7.36 € to 15.42 €.

Abivax currently has 62,928,818 shares in issue. The market capitalisation of Abivax is 487.70 € million. Abivax has a price to earnings ratio (PE ratio) of -3.17.

ABVX 최신 뉴스

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...

Abivax presents third quarter 2024 key financial information

Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the...

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax PARIS, France, November 13, 2024, 10:00 pm CET – Abivax SA (Euronext Paris and...

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation PARIS, France, October 7, 2024, 10:00...

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease PARIS, France, October 3, 2024 – 10:00 p.m. CEST – Abivax SA (Euronext Paris:...

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance Patients...

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024 Professor Bruce E. Sands, MD to present oral presentation of Phase 2b, open-label, maintenance efficacy...

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease...

Abivax presents first-half 2024 financial results

Abivax presents first-half 2024 financial results Cash balance of EUR 222M at June 30, 2024; cash runway in to Q4 2025 PARIS, France, September 9, 2024, 10:00 p.m. CEST – Abivax SA (Euronext...

Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) surpassed the...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.83-10.03627569538.278.347.36159687.90192523DE
4-2.31-23.69230769239.759.757.36241518.10447235DE
12-2.7-26.627218934910.1410.57.36226828.8622956DE
26-5.78-43.72163388813.2213.37.362004510.14630511DE
52-2.08-21.84873949589.5215.427.362543911.37494244DE
156-18.56-71.384615384626295.63162512.10215274DE
260-8.52-53.383458646615.9636.75.63264916.72980681DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ATOAtos SE
0.0026 €
(52.94%)
6B
NICBSNicox SA
0.0179 €
(47.93%)
240.74k
FIPPFipp
0.145 €
(28.32%)
70
ALPRIPrismaflex International
6.70 €
(27.62%)
7.16k
MLSMLSmalto
0.016 €
(23.08%)
2.59k
EXNExclusive Networks SA
18.84 €
(-22.15%)
14.35k
MLACTActivium Group
1.12 €
(-18.84%)
130
MLEFAEduformAction
0.41 €
(-16.33%)
8.16k
MLVERVerney Carron
5.25 €
(-16.00%)
600
ALBOOBOOSTHEAT
0.1715 €
(-14.25%)
12.41k
ATOAtos SE
0.0026 €
(52.94%)
6B
OPTICrescent NV
0.0102 €
(-7.27%)
449.67M
ALCYBCybergun
0.0001 €
(0.00%)
37.85M
BCPBanco Comercial Portugues SA
0.4407 €
(0.23%)
25.96M
ALTDTonner Drones
0.0118 €
(-3.28%)
17.36M
Golden Cross Golden Cross 2 초 전
$ILLR Check Out All The Hottest Celebrities Triller Has Partnered With!!

https://www.youtube.com/watch?v=I6jTiUZ03mQ
ILLR
Gmenfan Gmenfan 2 초 전
Ya think Peanut's up to the challenge?
Trooperstocks Trooperstocks 3 초 전
$CBDW 1606 Corp. AI Chatbots Innovations, Highlights Adnexus LOI, and Quarterly Reporting Update After Q3 Filling https://www.stocktitan.net/news/CBDW/1606-corp-target-for-strategic-investment-adnexus-biotechnologies-tqxh23dzqqw6.html
CBDW
1jas 1jas 48 초 전
good volume, but stuck.?
AFFU
Brocool Brocool 54 초 전
Kronos markets its products as Airdog and KRONOS brands. It serves to schools, universities, healthcare facilities, buses, manufacturing clean rooms and automobiles.$KNOS
KNOS
Maximilliano Maximilliano 57 초 전
Johnny, regarding your post about Exxon building the actual fuel cell manufacturing plants, as you know it's really all about money and demand. I would say demand, more than money, as illustrated below.

South Korea has a complete POSCO manufacturing plant for fuel cells sitting there,
FCEL
i_like_bb_stock i_like_bb_stock 58 초 전
SVMH grabbed some 029 probably runs a bit here may have one of those weird gaps too
SVMH
sundoctor sundoctor 58 초 전
what happening?
TSOI
MartinLutherKing MartinLutherKing 1 분 전
Management in bed with the shorts since inception
https://newsable.asianetnews.com/amp/markets/aptevo-therapeutics-stock-draws-retail-attention-after-leukemia-trial-data-retail-extremely-bullish-soe8pm
APVO
ReasearchThis ReasearchThis 1 분 전
Why would anyone want a $1++ eventually a
$5 to $20 a share stock to be trading for less than a penny?
.
I have asked several times why are AXXA Bashers here?
What caused AXXA Bashers to be AXXA Bashers?
never got an answer.
.
Here is another question
AXXA
ksquared ksquared 1 분 전
Trump says he won’t ‘do business’ with countries that refuse to take back migrants: ‘I want them out’
By Diana Glebova Published Dec. 12, 2024, 1:00 p.m. ET “We don’t want people to come in from jails. We don’t want the jails of Venezuela and many other countries, and not just South
timberwolf7 timberwolf7 1 분 전
Hope it works out for you, me, et al.

One caveat to be clear, they have a ways (TIME) to go...

and at this point, no idea what the 'justified' peak price could be IF
they are approved until sales, reimbursement prices, et al are announced.

My
AMPX
nowwhat2 nowwhat2 1 분 전
No trips down the rabbit hole for me......I go by what the markets say.

https://investorshub.advfn.com/uimage/uploads/2024/12/12/cfvnubtc_121212_10_5y_theory_low.jpg
XRPUSD
TenKay TenKay 2 분 전
The "shareholders" got $2.5 million in cash.

They got what was stated to be $17 million in equity in a private company...which since it is not publicly traded is illiquid even if it is actually worth that much.

They also got a pile of fertilizer somewhere in Brazil that
HMBL
norisknorewards norisknorewards 2 분 전
i don't think you're an engineer, i think you're paid by a SHF to post misleading trash (short of a few neutral posts) on social media to harm NWBO (if not other tickers as well).

besides, if you're an engineer employee, you best hope your employer doesn't see you bashing online all d
NWBO
Trooperstocks Trooperstocks 2 분 전
$ZENA now $7.55 +32.69% Heading back to its HOD AT $7.76 #Shortsqueeze #NEWS
ZENA
ORCA ORCA 2 분 전
I ADDED OVER 1,2 MILLION TODAY.IN THE .0069 AND .007.I GOT MORE BIDS WAITING.
12/12/2024 Buy
Trade Details
VPLM
VOIP-PAL COM INC
473,429
$0.007 $3.00 -$3,317.00
12/12/2024 Buy
Trade Details
VPLM
VOIP-PAL COM INC
300,000
VPLM
BlazingStocks BlazingStocks 3 분 전
$ILLR - Roadmap for the next-generation Triller App from Mr. Sean Kim (Chief Executive Officer of Triller App and the Company’s Triller Platform Co. subsidiary).
Operational efficiencies and transformation initiatives from Ms. Tasha Nikpey (Chief Operation Officer of Triller Corp.).
Up
ILLR
KILLAZILLA KILLAZILLA 3 분 전
"TROLLS"???

you HAVEN'T BEEN RIGHT ABOUT ANYTHING AND PVER 4 YEARS OF PUMPING GARBAGE!!!!
WDLF
learningcurve2020 learningcurve2020 3 분 전
Another one would be Tovorafenib.  


NWBO
tw0122 tw0122 3 분 전
It's a shame to get stuck but in penny land you imo you have to be a quick flipper and if you want to take extra risk only keep some of the gains from the quick flip running some more especially on these super tiny floaters where they have a much higher chance of offerings. 
APVO
tundra1 tundra1 3 분 전
Penny, please, new company, new operators. Relax. Of course you could look back and say oops. The PPS could catapult at any time.
Go ahead take that chance and CHASE.

GLTA
BIEI
Brocool Brocool 3 분 전
Kronos Advanced Technologies products move air silently, filter, sterilize, and purify the air while reducing energy consumption to half a 60-watt light bulb. $KNOS
KNOS

최근 히스토리

Delayed Upgrade Clock